BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 19962342)

  • 41. Evaluation of clinical and laboratory predictors of fatality in patients with Crimean-Congo haemorrhagic fever in a tertiary care hospital in Turkey.
    Hatipoglu CA; Bulut C; Yetkin MA; Ertem GT; Erdinc FS; Kilic EK; Sari T; Kinikli S; Oral B; Demiroz AP
    Scand J Infect Dis; 2010 Jul; 42(6-7):516-21. PubMed ID: 20166862
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Short report: Crimean-Congo hemorrhagic fever outbreak in Rawalpindi, Pakistan, February 2002.
    Athar MN; Baqai HZ; Ahmad M; Khalid MA; Bashir N; Ahmad AM; Balouch AH; Bashir K
    Am J Trop Med Hyg; 2003 Sep; 69(3):284-7. PubMed ID: 14628945
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Crimean Congo haemorrhagic fever, precautions and ribavirin prophylaxis: a case report.
    Tütüncü EE; Gurbuz Y; Ozturk B; Kuscu F; Sencan I
    Scand J Infect Dis; 2009; 41(5):378-80. PubMed ID: 19343611
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Crimean-Congo Hemorrhagic Fever].
    Güneş T
    Mikrobiyol Bul; 2006 Jul; 40(3):279-87. PubMed ID: 17001860
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Peripheral blood natural killer cells in Crimean-Congo hemorrhagic fever.
    Yilmaz M; Aydin K; Akdogan E; Sucu N; Sonmez M; Omay SB; Koksal I
    J Clin Virol; 2008 Aug; 42(4):415-7. PubMed ID: 18434247
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Crimean Congo hemorrhagic fever in Hazara division.
    Malik S; Diju IU; Naz F
    J Ayub Med Coll Abbottabad; 2011; 23(2):90-2. PubMed ID: 24800352
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum nitric oxide levels in patients with Crimean-Congo haemorrhagic fever.
    Tütüncü EE; Gurbuz Y; Ozturk B; Kuscu F; Sencan I
    Scand J Infect Dis; 2010 May; 42(5):385-8. PubMed ID: 20095935
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bradycardia related to ribavirin in four pediatric patients with Crimean-Congo hemorrhagic fever.
    Tezer H; Ozkaya Parlakay A; Gülhan B; Cetin I
    Vector Borne Zoonotic Dis; 2014 Jun; 14(6):464-5. PubMed ID: 24745325
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Crimean-Congo hemorrhagic fever in Southeast of Iran.
    Alavi-Naini R; Moghtaderi A; Koohpayeh HR; Sharifi-Mood B; Naderi M; Metanat M; Izadi M
    J Infect; 2006 May; 52(5):378-82. PubMed ID: 16182370
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [A Case of Simultaneous Acute Lymphoblastic Leukemia Diagnosis with Crimean-Congo Hemorrhagic Fever].
    Çayıröz P; Çayıröz MU; Iltar U; Kurtoğlu E
    Mikrobiyol Bul; 2020 Apr; 54(2):326-333. PubMed ID: 32723287
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of children with Crimean-Congo hemorrhagic fever in the central Blacksea region.
    Belet N; Top A; Terzi O; Arslan HN; Baysal K; Sensoy G
    Pediatr Infect Dis J; 2014 Aug; 33(8):e194-7. PubMed ID: 24463803
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The frequency of self-reported allergic diseases in patients with crimean-congo haemorrhagic fever.
    Abadoglu O; Engin A
    Allergol Immunopathol (Madr); 2009; 37(5):234-8. PubMed ID: 19775796
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of the association of serum levels of hyaluronic acid, sICAM-1, sVCAM-1, and VEGF-A with mortality and prognosis in patients with Crimean-Congo hemorrhagic fever.
    Ozturk B; Kuscu F; Tutuncu E; Sencan I; Gurbuz Y; Tuzun H
    J Clin Virol; 2010 Feb; 47(2):115-9. PubMed ID: 20005156
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Early use of ribavirin is beneficial in Crimean-Congo hemorrhagic fever.
    Ozbey SB; Kader Ç; Erbay A; Ergönül Ö
    Vector Borne Zoonotic Dis; 2014 Apr; 14(4):300-2. PubMed ID: 24689859
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [A case of Crimean-Congo hemorrhagic fever with long incubation period in Kocaeli, Turkey].
    Meriç Koç M; Willke A
    Mikrobiyol Bul; 2012 Jan; 46(1):129-33. PubMed ID: 22399182
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Viral load as a predictor of outcome in Crimean-Congo hemorrhagic fever.
    Cevik MA; Erbay A; Bodur H; Eren SS; Akinci E; Sener K; Ongürü P; Kubar A
    Clin Infect Dis; 2007 Oct; 45(7):e96-100. PubMed ID: 17806044
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mean platelet volume in the diagnosis and prognosis of Crimean-Congo hemorrhagic fever.
    Ekiz F; Gürbüz Y; Basar Ö; Aytekin G; Ekiz Ö; Sentürk ÇŞ; Aktas B; Yılmaz B; Altınbaş A; Çoban Ş; Şencan İ
    Clin Appl Thromb Hemost; 2013; 19(4):441-4. PubMed ID: 22431857
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ocular findings in patients with Crimean-Congo hemorrhagic fever.
    Engin A; Erdogan H; Ozec AV; Elaldi N; Toker MI; Bakir M; Dokmetas I; Arici MK
    Am J Ophthalmol; 2009 Apr; 147(4):634-638.e1. PubMed ID: 19195635
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Crimean-Congo hemorrhagic fever: a first case from Abbottabad, Pakistan.
    Saleem J; Usman M; Nadeem A; Sethi SA; Salman M
    Int J Infect Dis; 2009 May; 13(3):e121-3. PubMed ID: 19008137
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bradycardia seen in children with Crimean-Congo hemorrhagic fever.
    Oflaz MB; Kucukdurmaz Z; Guven AS; Karapinar H; Kaya A; Sancakdar E; Deveci K; Gul I; Erdem A; Cevit O; Icagasioglu FD
    Vector Borne Zoonotic Dis; 2013 Nov; 13(11):807-11. PubMed ID: 24107209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.